Literature DB >> 10336501

Specificity for fibroblast growth factors determined by heparan sulfate in a binary complex with the receptor kinase.

M Kan1, X Wu, F Wang, W L McKeehan.   

Abstract

A divalent cation-dependent association between heparin or heparan sulfate and the ectodomain of the FGF receptor kinase (FGFR) restricts FGF-independent trans-phosphorylation and supports the binding of activating FGF to self-associated FGFR. Here we show that in contrast to heparin, cellular heparan sulfate forms a binary complex with FGFR that discriminates between FGF-1 and FGF-2. FGFR type 4 (FGFR4) in liver parenchymal cells binds only FGF-1, whereas FGFR1 binds FGF-1 and FGF-2 equally. Cell-free complexes of heparin and recombinant FGFR4 bound FGF-1 and FGF-2 equally. However, in contrast to FGFR1, when recombinant FGFR4 was expressed back in epithelial cells by transfection, it failed to bind FGF-2 unless heparan sulfate was depressed by chlorate or heparinase treatment. Isolated heparan sulfate proteoglycan (HSPG) from liver cells in cell-free complexes with FGFR4 restored the specificity for FGF-1 and supported the binding of both FGF-1 and FGF-2 when complexed with FGFR1. In contrast, FGF-2 bound equally well to complexes of both FGFR1 and FGFR4 formed with endothelial cell-derived HSPG, but the endothelial HSPG was deficient for the binding of FGF-1 to both FGFR complexes. These data suggest that a heparan sulfate subunit is a cell type- and FGFR-specific determinant of the selectivity of the FGFR signaling complex for FGF. In a physiological context, the heparan sulfate subunit may limit the redundancy among the current 18 FGF polypeptides for the 4 known FGFR.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10336501     DOI: 10.1074/jbc.274.22.15947

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  53 in total

1.  Directional specificity of prostate stromal to epithelial cell communication via FGF7/FGFR2 is set by cell- and FGFR2 isoform-specific heparan sulfate.

Authors:  M Kan; F Uematsu; X Wu; F Wang
Journal:  In Vitro Cell Dev Biol Anim       Date:  2001-10       Impact factor: 2.416

Review 2.  Cellular cofactors for amyloid beta-peptide-induced cell stress. Moving from cell culture to in vivo.

Authors:  S D Yan; A Roher; A M Schmidt; D M Stern
Journal:  Am J Pathol       Date:  1999-11       Impact factor: 4.307

3.  Increased carbon tetrachloride-induced liver injury and fibrosis in FGFR4-deficient mice.

Authors:  Chundong Yu; Fen Wang; Chengliu Jin; Xiaochong Wu; Wai-kin Chan; Wallace L McKeehan
Journal:  Am J Pathol       Date:  2002-12       Impact factor: 4.307

4.  Up-regulation of the chondrogenic Sox9 gene by fibroblast growth factors is mediated by the mitogen-activated protein kinase pathway.

Authors:  S Murakami; M Kan; W L McKeehan; B de Crombrugghe
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-01       Impact factor: 11.205

5.  Evidence for digenic inheritance in some cases of Antley-Bixler syndrome?

Authors:  W Reardon; A Smith; J W Honour; P Hindmarsh; D Das; G Rumsby; I Nelson; S Malcolm; L Adès; D Sillence; D Kumar; C DeLozier-Blanchet; S McKee; T Kelly; W L McKeehan; M Baraitser; R M Winter
Journal:  J Med Genet       Date:  2000-01       Impact factor: 6.318

Review 6.  Endovascular laser–tissue interactions and biological responses in relation to endovenous laser therapy.

Authors:  Michal Heger; Rowan F van Golen; Mans Broekgaarden; Renate R van den Bos; H A Martino Neumann; Thomas M van Gulik; Martin J C van Gemert
Journal:  Lasers Med Sci       Date:  2014-03       Impact factor: 3.161

Review 7.  The extracellular matrix in development and morphogenesis: a dynamic view.

Authors:  Tania Rozario; Douglas W DeSimone
Journal:  Dev Biol       Date:  2009-10-23       Impact factor: 3.582

Review 8.  Syndecan-4: dispensable or indispensable?

Authors:  Sarah A Wilcox-Adelman; Fabienne Denhez; Tokuro Iwabuchi; Stefania Saoncella; Enzo Calautti; Paul F Goetinck
Journal:  Glycoconj J       Date:  2002 May-Jun       Impact factor: 2.916

9.  Inhibition of fibroblast growth factor receptor signaling impairs metastasis of hepatocellular carcinoma.

Authors:  Jiajun Wang; Hongying Su; Xiangjun Han; Ke Xu
Journal:  Tumour Biol       Date:  2014-08-05

10.  HIP/RPL29 antagonizes VEGF and FGF2 stimulated angiogenesis by interfering with HS-dependent responses.

Authors:  Sonia D'Souza; Weidong Yang; Dario Marchetti; Caroline Muir; Mary C Farach-Carson; Daniel D Carson
Journal:  J Cell Biochem       Date:  2008-12-01       Impact factor: 4.429

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.